Another top level appointment has been announced at Nasdaq Stockholm listed Oncopeptides, a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases. Following on from news…
Another top level appointment has been announced at Nasdaq Stockholm listed Oncopeptides, a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases. Following on from news…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


